Tag : Doxorubicin

Pharma / Biotech

A new tandem peptide modified liposomal doxorubicin for tumor "ecological therapy".

Newsemia
Related Articles A new tandem peptide modified liposomal doxorubicin for tumor “ecological therapy”. Nanoscale. 2020 Feb 07;12(5):3359-3369 Authors: Zhao T, Zhou H, Lei L, Guo...
Cardiology

TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity.

Newsemia
Related Articles TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity. Biology (Basel). 2020...
Pharma / Biotech

Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy.

Newsemia
Related Articles Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy. Molecules. 2020 Jan 14;25(2): Authors: Nogueira J, Soares SF, Amorim CO, Amaral JS,...
Cardiology

Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin.

Newsemia
Related Articles Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin. Sci Rep. 2020 Oct 28;10(1):18481 Authors:...
Pharma / Biotech

Hyaluronic acid modified doxorubicin loaded Fe3O4 nanoparticles effectively inhibit breast cancer metastasis.

Newsemia
Related Articles Hyaluronic acid modified doxorubicin loaded Fe3O4 nanoparticles effectively inhibit breast cancer metastasis. J Mater Chem B. 2019 10 14;7(38):5861-5872 Authors: Gong T, Dong...
Latest News

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Newsemia
Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of the investigational agent cediranib to olaparib and standard platinum-based chemotherapy...
Pharma / Biotech

Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: Estimation of doxorubicin hepatic extraction ratio.

Newsemia
Related Articles Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: Estimation of doxorubicin hepatic extraction ratio....
Latest News

Global Thyroid Cancer Drugs Market Report 2020: Focus on Ipilimumab, Cabozantinib-S-Malate, Caprelsa, Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Thyroid Cancer Drugs Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. The global thyroid cancer drugs market was valued at...
Latest News

Researchers confirm two new prognostic markers for triple negative breast cancer

Newsemia
Physicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery treatment...
Pharma / Biotech

A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market.

Newsemia
Related Articles A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market. J Control Release. 2019 Nov 18;: Authors: Gonçalves M, Mignani...
Cardiology

The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes.

Newsemia
Related Articles The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes. Chem Biol Interact. 2019 Sep 20;:108834 Authors: Hanf A, Oelze M, Manea...
Latest News

Early marker of cardiac damage triggered by cancer treatment identified

Newsemia
Every year, 4 million new cases of cancer are diagnosed in Europe. Advances in cancer treatment sometimes come at the cost of major adverse effects,...
Latest News

Combination approach appears to improve chemotherapy response, boost anti-tumor immunity

Newsemia
Scientists at the University of Toronto’s Leslie Dan Faculty of Pharmacy have seen remarkable success combining tumor modulating nanoparticles with doxorubicin to enhance chemotherapy response...
Gastroenterology

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Newsemia
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint. Source link...
Pharma / Biotech

Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer.

Newsemia
Related Articles Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer. Biomed Pharmacother. 2018 Sep 19;108:565-573 Authors: Zheng W, Li...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy